Levo-Alphacetylmethadol
Levo-Alphacetylmethadol Brand names, Levo-Alphacetylmethadol Analogs
Levo-Alphacetylmethadol Brand Names Mixture
- No information avaliable
Levo-Alphacetylmethadol Chemical_Formula
C23H31NO2
Levo-Alphacetylmethadol RX_link
http://www.rxlist.com/cgi/generic2/levomethadyl.htm
Levo-Alphacetylmethadol fda sheet
Levo-Alphacetylmethadol msds (material safety sheet)
Levo-Alphacetylmethadol Synthesis Reference
No information avaliable
Levo-Alphacetylmethadol Molecular Weight
353.498 g/mol
Levo-Alphacetylmethadol Melting Point
No information avaliable
Levo-Alphacetylmethadol H2O Solubility
>15 mg/mL
Levo-Alphacetylmethadol State
Solid
Levo-Alphacetylmethadol LogP
6.139
Levo-Alphacetylmethadol Dosage Forms
Solution
Levo-Alphacetylmethadol Indication
LAAM is indicated for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients.
Levo-Alphacetylmethadol Pharmacology
LAAM is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, LAAM is more active and more toxic than morphine. The principal actions of therapeutic value are analgesia and sedation and detoxification or temporary maintenance in narcotic addiction. The LAAM abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe.
Levo-Alphacetylmethadol Absorption
LAAM is rapidly absorbed from an oral solution.
Levo-Alphacetylmethadol side effects and Toxicity
Signs of overdose include apnea, circulatory collapse, pulmonary edema, cardiac arrest, and death.
Levo-Alphacetylmethadol Patient Information
No information avaliable
Levo-Alphacetylmethadol Organisms Affected
Humans and other mammals
